Startups

Quaternity ApS

Hørsholm, Denmark · Rungsted Kyst, Denmark

linkedin.comg-mendel.com

Quaternity ApS is a privately held Danish corporate holding company, CVR41493607, associated with biotechnology and precision medicine through disclosed backing of gMendel. Its own2025 annual financial statements, approved and signed June25,2026, identify registered office Hørsholm, Denmark and director Christos Kyriakidis, the same executive publicly known as gMendel co-founder/CEO Chris Kyriakidis. The signed statements describe its primary activities as a holding company and related business; this is not evidence of an independent external-LP venture manager. gMendel’s2022 signed annual report identifies Quaternity as joint-tax-group administration company; its2022,2023 and2025 issuer reviews separately name Quaternity among private funding supporters. Those corporate support disclosures are distinguished from personal founder checks, exact individual allocation, ownership percentage or an inferred financing instrument. The company-controlled public LinkedIn page describes biotechnology research and names Chris Kyriakidis as its sole publicly visible professional affiliation. Its generic2–10employee range is not a verified staff roster: the actual2025 statements report zero average employees. The published director is included as governance, not an invented paid employee. No genuine company brandmark, additional verified public management names, external-LP funds, fund closing amounts or unrelated portfolio investments were established. The LinkedIn child-image cover and annual-report accountant Beierholm logo are excluded from the company image. Share capital, group receivables, accounting assets and intercompany tax balances are not fund closings or priced funding tickets.

Founded 2020

Team

Chris KyriakidisChris KyriakidisDirector — documented June 2026

Investments